NSC |
Compound |
Enrichment |
Correlation |
NSC 5639 |
Null |
0.029334167004364 |
0.47023991 |
NSC 721041 |
Null |
0.029334167004364 |
0.49924701 |
NSC 750717 |
5-(2-hydroxyethyl)-9-(3-methoxyphenyl)-6,9-dihydro-[1,3]dioxolo[4,5-g]furo[3,4-b]quinolin-8(5H)-one |
0.0293341670043648 |
0.42526844 |
NSC 81206 |
Null |
0.0293341670043648 |
0.036794981 |
NSC 751830 |
2-(4-hydroxypiperidin-1-yl)-4-(4-morpholinophenylamino)pyrido[4,3-d]pyrimidin-5(6H)-one |
0.0295480456086945 |
-0.042104819 |
NSC 132791 |
Butyric acid, 2-hydroxy-2-methyl-, 4-ester with 1,3a.beta.,4,7,7a.alpha.,11,11a,11b.alpha.-octahydro-1.alpha.,2.alpha.,4.beta.,11.beta.-tetrahydroxy-3.alpha.,8,11a.beta.-trimethyl-2H-1,11c.beta.-(epo |
0.0295480456086947 |
0.21494256 |
NSC 168516 |
Benzene, 1,1'-(1,2-ethanediyl)bis[2,5-dimethoxy- |
0.0295480456086947 |
0.38878067 |
NSC 175493 |
Iron, carbonyl(.eta.(5)-2,4-cyclopentadien-1-yl)(dimethylcarbamodithioato-S,S')- |
0.0295480456086947 |
0.43991736 |
NSC 295272 |
Null |
0.0295480456086947 |
0.15496295 |
NSC 357777 |
Null |
0.0295480456086947 |
0.11015718 |